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Background: In recent years, issues in medical business ethics (MBE), such as conflicts of interest (COI), Medicare
fraud and abuse, and the structure and functioning of reimbursement systems, have received significant attention
from the media and professional associations in the United States. As a result of highly publicized instances of
financial interests altering physician decision-making, major professional organizations and government bodies have
produced reports and guidelines to encourage self-regulation and impose rules to limit physician relationships with
for-profit entities. Nevertheless, no published curricula exist in the area of MBE. This study aimed to establish a
baseline level of knowledge and the educational goals medical students and residents prioritize in the area of MBE.
Methods: 732 medical students and 380 residents at two academic medical centers in the state of Missouri, USA,
completed a brief survey indicating their awareness of major MBE guidance documents, knowledge of key MBE
research, beliefs about the goals of an education in MBE, and the areas of MBE they were most interested in
learning more about.
Results: Medical students and residents had little awareness of recent and major reports on MBE topics, and had
minimal knowledge of basic MBE facts. Residents scored statistically better than medical students in both of these
areas. Medical students and residents were in close agreement regarding the goals of an MBE curriculum. Both
groups showed significant interest in learning more about MBE topics with an emphasis on background topics
such as “the business aspects of medicine” and “health care delivery systems”.
Conclusions: The content of major reports by professional associations and expert bodies has not trickled down to
medical students and residents, yet both groups are interested in learning more about MBE topics. Our survey
suggests potentially beneficial ways to frame and embed MBE topics into the larger framework of medical
education.
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In the market context of medicine in the United States,
issues in medical business ethics (MBE), such as con-
flicts of interest (COI), Medicare fraud and abuse, and
the structure and functioning of reimbursement systems,
affect the integrity of medical practice and research.
Substantial data indicate that self-serving bias subcon-
sciously influences the way physicians weigh information
and make decisions when financial incentives exist [1].
Financial relationships between physicians and medical
industry are ubiquitous [2] and have measurable effects
on physician behavior [3,4]. The business dimensions of
medicine add complexity to physicians’ daily decisions
about patient care [5,6], and cases of physicians who
prioritize profit over the safety and health of patients are
regularly made public [7-10]. These cases undermine
public trust, leading to questions about the validity of re-
search results and clinical decisions.
The Institute of Medicine (IOM) [11], the Association of
American Medical Colleges [12,13], the American Medical
Student Association [14], the Office of the Inspector
General (OIG) [15], and the U.S. Congress [16], share
these concerns as indicated by reports and guidelines on
such topics published over recent years. Most encourage
self-regulation by the profession while imposing rules that
can be frustrating for clinicians and scientists [17].
Attitudes toward industry are formed early in medical
training [18], suggesting the need for early MBE education.
The Accreditation Council for Graduate Medical Educa-
tion (ACGME) lists both professionalism (which includes
ethics) and systems-based practice (which includes aware-
ness of the larger context and system of health care and its
resources) as two of their six core competencies of patient
care [19]. Medical students and residents generally support
initiatives in ethics and professionalism [20]. Nevertheless,
many important ethical issues, such as Medicaid and
Medicare fraud and abuse, are not uniformly presented to
training physicians in the United States [21].
Furthermore, although there are no data to indicate
graduating residents’ views, the majority of graduating
medical students believe current instruction and the ex-
posure they have in medical school to health policy and
economics has poorly prepared them for entrance into
the US healthcare system [22]. Knowledge of health
policy and economics is only the beginning of under-
standing the myriad ethical issues intricately entwined in
the financial relationships that are involved in medical
practice and applying this understanding to professional
practice. Current ethics education is lacking in both this
foundational knowledge as well as its related ethical co-
nundrums [23].
The AMSA PharmFree Scorecard Methodology rates
academic medical centers on the quality of their policies
and practices regarding conflicts of interest, includingthe provision of an adequate curriculum for medical stu-
dents on conflicts of interest. They specifically examine
whether “Students are trained to understand institu-
tional conflict-of-interest policies and recognize how in-
dustry promotion can influence clinical judgment [24]”.
While this concentrates attention on just one aspect of
MBE, it reflects a growing awareness of the importance
of MBE for medical ethics and professionalism over the
past decade: In 2002, fewer than 1 in 4 academic medical
center’s ethics curriculum dedicated attention to COIs
(DuBois and Burkemper 2002).
The Bander Center for Medical Business Ethics at
Saint Louis University (Bander Center), with whom the
four authors are affiliated, has established the goal of
publishing a freely available, online case-based curri-
culum in this area. This paper reports on a preliminary
step in that process: Surveying medical students and re-




In January and February 2013, a brief, confidential sur-
vey was emailed to medical students and residents at
Saint Louis University (SLU) and Washington University
(WU) in Saint Louis, Missouri. Among those invited,
720 were medical students at SLU, 576 were medical
students at WU (n = 1296), 617 were residents at SLU,
and 562 were residents at WU (n = 1179) for a total of
2475. These medical schools incorporate both scheduled
and elective courses in healthcare ethics and health pol-
icy as part of the required medical doctorate curricula;
formal ethics instruction at both institutions occurs pri-
marily during the preclinical years (MS1 and MS2). Resi-
dents at these institutions have less formalized training
in ethics that may include lectures and ethics continuing
medical education (CME). The 2013 AMSA Scorecard
on “Conflicts of Interest Policies in Academic Medical
Centers” graded the policies at WU with an “A” and pol-
icies at SLU with a “B”.
Questionnaire and distribution
A nine-item questionnaire was distributed using Qual-
trics, a web-based survey software system. Invitations
were sent over three weeks. Following the initial invita-
tion, reminder emails were sent after the end of week
one and week two to individuals who had not yet re-
plied. As an incentive to complete the survey, we offered
participants at each institution the chance to win an
iPad Mini or one of two $50 gift cards; a total of six
prizes were awarded using a lottery method.
Participants were asked to select their affiliated aca-
demic medical center and their level of medical training.
They were asked how familiar they were with four major
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of Medicine (IOM) report entitled “Conflict of Interest
in Medical Research, Education, and Practice” [11]; The
Office of Inspector General (OIG) self-study booklet enti-
tled “A Roadmap for New Physicians: Avoiding Medicare
and Medicaid Fraud and Abuse” [15]; The Pharmaceutical
Research and Manufacturers of America (PhRMA) report
entitled “Code on Interactions with Healthcare Pro-
fessionals” [25]; and The Association of American Medical
Colleges (AAMC) report entitled “In the Interest of
Patients: Recommendations for Physician Financial Rela-
tionships and Clinical Decision Making” [12]. They could
choose one of three answers: “not at all”, “heard of it”, or
“familiar with its content”. We believed that familiarity
with some of the reports that drove policy development
within academic medical centers would reflect awareness
of developments in the area of conflicts of interest and
medical business ethics. This seemed appropriate given
that literature on medical business ethics is still in its in-
fancy, and the Institute of Medicine Report has been cited
widely by the AAMC and has been used by the authors in
educational sessions with medical students and residents.
The next four multiple-choice questions tested partici-
pants’ knowledge of key research on MBE: the prevalence
of physician relationships with medical industry [2], the
nature of self-serving bias [1], how much pharmaceutical
companies spend on marketing free drug samples [26],
and the Bayh-Dole Act of 1980, which allows government-Table 1 MBE awareness questions
Item: How familiar are you with the following guidance documents?
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** = p < .01 MS n = 732, PG n = 380.funded research discoveries to be patented by research
institutions and royalty income to be shared with investi-
gators [27].
The final two questions captured medical students’
and residents’ beliefs about the goals of an education in
MBE, and the areas of MBE they were most interested
in learning more about.
This study was approved by the Institutional Review
Board (IRB) at Saint Louis University.Analysis
Survey data were analyzed using the Statistical Package
for the Social Sciences (SPSS). Statistical analysis focused
on descriptive statistics and the comparison of medical
students (MS) and post-graduate residents (PG) using
Chi square.Results and discussion
The survey response rate was 45% (n = 1112). Respon-
dents were evenly split between institutions: 553 from
SLU (50%) and 559 from WU (50%). Respondents in-
cluded 732 medical students (65%)—MS1 (16%), MS2
(16%), MS3 (12%), MS4 (13%), MD/PhD (8%)—and 380
residents (34%)—PGY1 (6%), PGY2 (7%), PGY3 (6%),
PGY4 (5%), and PGY5 (4%), and PGY > 5 (6%).
Tables 1, 2, 3 and 4 present participant responses to



















Table 2 MBE knowledge questions
Item stem with correct response in boldface MS % PG % X2
Estimate the percentage of academic physicians that have a financial relationship with industry? …
5 – 15% 7.5% 11.8%
15 – 25% 34.4% 41.6%
25 – 50% 32.2% 28.9%
> 50% 14.1% 10.8% 17.6**
I don’t know 7.7% 6.8%
As noted in the AAMC and IOM documents on conflicts of interest in medicine, social science data suggests that
“Self-serving bias is difficult to manage through disclosure alone”. 49.2% 58.9% 26.2**
“Disclosure of conflicts of interest is sufficient to protect patients’ interests”. 5.9% 10.5%
“Most physicians will not disclose their conflicts of interest even when required”. 6.7% 6.1%
“Physicians with antisocial personalities harm patients when they have conflicts of interest”. 0.7% 0.5%
I don’t know 37.6% 23.9%
What percentage of the marketing budget of pharmaceutical companies is spent on free drug samples? …
10% 12.3% 15.8%
25% 26.9% 32.9%
50% 19.7% 24.7% 23.3**
75% 5.9% 3.2%
I don’t know 35.2% 23.4%
The Bayh-Dole Act of 1980 allows academic medical centers that receive government research funding to:
“Collaborate with private industry in medical research”. 10.4% 18.7%
“Retain the copyright on all scientific publications produced by faculty”. 4.1% 6.1%
“Patent discoveries made with government research funding”. 10.7% 14.5% 27.2**
“Bill for faculty salaries at a rate equal to the highest government employee salary”. 0.3% 0.8%
I don’t know 74.6% 60.0%
** = p < .01 MS n = 732, PG n = 380.
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Overall, participants had little awareness of recent,
major reports addressing MBE topics (see Table 1). The
vast majority of medical students had never heard of any
of the reports, and almost no students had familiarity
with them. One third to half of residents had at least
heard of some of the four reports; overall residents had
significantly more awareness and familiarity with these
reports than medical students.Table 3 Goals of learning about MBE
Item: An education in medical business ethics is important insofar as it
following goals:
To avoid legal problems (e.g., avoid Medicare fraud).
To prioritize patients’ best interests over the financial interests of others (such
or physician practices).
To foster the common good by being good stewards of limited healthcare d
To achieve their own financial goals as physicians without violating the law o
Responses used a 5-point Likert-type scale from 1 (strongly agree) to 5 (strongly dis
* = p < .05 MS n = 732, PG n = 380.Knowledge of MBE
As indicated in Table 2, medical student and resident
knowledge of basic MBE facts was minimal. Similar to
the first set of questions on general awareness of major
reports on MBE, residents knew significantly more than
medical students (see Table 2).
The highest percentage of correct answers came in re-
sponse to the second question: “As noted in the AAMC
and IOM documents on conflicts of interest in medicine,helps physicians to meet the MS mean (SD) PG mean (SD) t
1.83 (.75) 1.87 (.74) -.81
as 3rd party payers, industry, 1.71 (.79) 1.82 (.83) −2.1*
ollars. 1.93 (.81) 1.97 (.86) -.90
r rules for professionalism. 2.10 (.84) 2.12 (.83) -.33
agree).
Table 4 MBE areas of interest to participants
Item: What areas of medical business ethics are you most interested in learning more about?
(Check as many as apply)
MS % PG % X2
Physician-industry interactions in clinical practice (e.g., interactions with drug and device reps) 61.2% 41.3% 39.9**
Regulation of physician business practices (e.g. fraud laws) 39.3% 43.7% 2.0
Whistleblowing (e.g. when and how to report medical fraud) 31.0% 19.2% 17.7**
The business aspects of medicine (e.g., billing, coding, and reimbursement systems) 61.5% 69.5% 7.0**
Health care delivery systems (e.g., understanding managed care, employer-based insurance, single payer systems, etc.) 63.7% 54.5% 8.8**
Health care access, rationing, resource allocation 59.3% 42.6% 27.9**
Physician organizations and political activism 26.0% 20.5% 4.0*
Physicians as employees 38.8% 32.1% 4.8*
Physicians as owners of medical practices 41.4% 37.6% 1.5
Professionalism and self-regulation 24.7% 23.9% .08
Conflicts of interest in medical research 33.7% 25.3% 8.4**
Physicians as owners of intellectual property and data 34.4% 34.7% .01
* = p < .05 ** = p < .01 MS n = 732, PG n = 380.
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ficult to manage through disclosure alone.’” Although the
answer to this question may be more intuitive when com-
pared to the other questions in this section testing know-
ledge, the fact that residents and medical students are
aware of self-serving bias and its need to be managed more
effectively is interesting, given that this thesis has been
generally difficult for practicing physicians to accept [1]. In
fact, physicians have often expressed that they are above
these biases, and that they are able to make objective deci-
sions despite relationships with industry that may pose a
personal financial incentive [28,29].
Of note, only 5 participants answered all 4 knowledge
questions correctly. That is .4% of all participants, which
is precisely the percent expected with random guessing
(.25 × .25 × .25 × .25 = .004 or .4%).
Goals of learning MBE topics
In contrast to the basic MBE awareness and knowledge
questions, medical students and residents were in close
agreement on what they believed the goals of an MBE
curriculum should be (see Table 3). The most strongly
endorsed goal for both groups was for physicians “to
prioritize patients’ best interests over the financial inter-
ests of others (such as third party payers, industry, or
physician practices)” (m = 1.73 on a 5 point scale with 1
being strongly agree). This prioritization suggests their
interest in these topics is not merely in order to obey
laws and rules, but to understand how to uphold a true
level of professionalism and put their patients’ best inter-
ests first. Recent research of medical student exposure to
and attitudes about pharmaceutical companies reinforces
the uncertainty they feel about how to manage these
conflicts [30], and that their attitudes can be shaped by
the substantial contact they have with pharmaceuticalmarketing even during undergraduate medical education
[18]. Their strong agreement with all goals presented indi-
cates they view this knowledge as important to their me-
dical education and that they are sensitive to the tension it
places on their decision-making. These findings reinforce
the recommendations of the 2008 AAMC report on
“Industry Support of Medical Education”, which recom-
mended that
Educational programs should be developed to raise
the awareness among students, trainees, and faculty of
challenges to professionalism presented by certain
interactions with industry and to provide
opportunities that help them build critical evaluation
skills that reinforce high individual standards, norms,
and behaviors. P. 11.
MBE topics of interest
There was a significant amount of interest by both groups
in learning more about numerous MBE topics (see Table 4).
The topics with the most interest from both groups were
“the business aspects of medicine (e.g., billing, coding,
and reimbursement systems)”, and “health care delivery
systems (e.g., understanding managed care, employer-
based insurance, single payer systems, etc.)”. Students
and residents were slightly more interested in learning
the basics of the business of medicine than the related
ethical issues. We included these “basics of business”
topics in our list because a separate Delphi survey we
conducted with leaders throughout the US indicated
that business ethics instruction should include a foun-
dation in the business aspects of medicine [31].
Both groups were least interested in learning about
“physician organizations and political activism”, “pro-
fessionalism and self-regulation”, and “whistleblowing”.
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aspects of these issues are encountered as the individual
physician interacts with the larger medical system; our
participants were less concerned with the interaction of the
profession as a whole with the healthcare delivery system.
Although many topics received high interest from both
groups, there were statistically significant differences
between medical students and residents on seven of
twelve topics. In general, medical students indicated
more interest in the listed topics than residents, per-
haps due to differences in level of responsibility and
specific duties at the clinical level, experience, know-
ledge, and exposure to these issues.
We additionally provided participants with a textbox
to write in topics of interest. Six medical students wrote
in topics, some of which were new, and some of which
specified topics in our list: Personal charity and free ser-
vice; getting government out of healthcare regulation;
transparency in medical billing; unethical retention of
research data by pharmaceutical companies; physician
entrepreneurship in an area outside of practicing medi-
cine directly; the need to spend more time with patients
even though fee for service medicine discourages this.
No residents chose to write in a response.
Conclusions
Our survey is limited by a response rate of 45%. Although
a higher response rate would have been desirable, it seems
unlikely that nonresponders would have been more fa-
miliar with MBE—one would expect interest in survey par-
ticipation would increase if it were a topic familiar to the
individual. Our survey is also limited by the number of
items. A greater number of items would have more reliably
assessed participants’ knowledge of MBE topics. However,
a longer questionnaire would likely have reduced response
rates. Moreover, the answers to the knowledge items
selected were representative of facts frequently men-
tioned in the major reports on MBE that provided a
focus for our project. We would also emphasize that our
project focused only on education in medical business
ethics. As the AMSA scorecard criteria rightly observe,
this is just one component to navigating successfully busi-
ness ethics in medicine, a component that must be supple-
mented by appropriate policies, mentoring, and practices.
Identifying needs and interests
When groups such as the AAMC or IOM produce re-
ports on matters such as conflicts of interest, it is often
with the purpose of educating the profession and pro-
viding guidance. Our survey results indicate that these
reports are not reaching young professionals who are
supposed to benefit from their content. Residents were
more knowledgeable than medical students and more
aware of major reports on MBE, indicating thatresidency provides some exposure to such information,
but overall the impact of resident experience alone is
modest. These findings help to justify an increased focus
on MBE topics within medical training programs.
Framing a curriculum in MBE
The findings of this survey not only demonstrate a need
for MBE education, but also provide guidance on how
best to frame such a curriculum to meet the needs and
interests of medical students and residents.
Curricula should frame MBE topics in terms of their
impact on patient care. Doing so is not only consistent
with guidance from the AAMC [13], but also reflects the
priorities of medical students and residents.
We also recommend that the MBE curriculum be em-
bedded in instruction on health care systems rather than
in general medical ethics courses. This reflects the greater
interest participants expressed in learning the basics of the
business of medicine (health care delivery and reim-
bursement systems) than the related, more overtly ethical
issues. But it also makes excellent sense from the perspec-
tive of ethics pedagogy. Combining the business aspects of
medical practice with related ethical issues situates ethical
theory in real-world dilemmas and reinforces the idea that
ethics is not separate from medical professionalism, but is
an essential dimension of it [17,32].
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